Free Trial

LogicBio Therapeutics (LOGC) Earnings Date, Estimates & Call Transcripts

LogicBio Therapeutics logo
$15.05 -0.10 (-0.66%)
As of 10:34 AM Eastern

LogicBio Therapeutics Earnings Summary

LogicBio Therapeutics posted Q3 2026 earnings on November 9, 2026, reporting an EPS of -$0.29, which missed the consensus estimate of -$0.04 by $0.25. LogicBio Therapeutics currently has a trailing EPS of -$0.73

Latest Q3
Earnings Date
Nov. 9Estimated
Consensus EPS
(Nov. 9)
-$0.04
Actual EPS
(Nov. 9)
-$0.29 Missed By -$0.25

Q3 2026 Earnings Resources

LOGC Upcoming Earnings

LogicBio Therapeutics will be holding an earnings conference call on Monday, November 9, 2026 on Monday, November 9, 2026 at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get LogicBio Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LogicBio Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

LOGC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LOGC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

LogicBio Therapeutics Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/9/2026Q3 2026-$0.0419-$0.29 -$0.2481-$0.29$23.31M-
8/13/2026Q2 2026-$0.0414-$0.14 -$0.0986-$0.14$33.60M$33.60M
5/9/2025Q1 2025--$0.27--$0.27--
3/12/2025Q4 2024--$0.08--$0.08--

Earnings data for OTCMKTS:LOGC is sourced from Fiscal.ai, with the most recent quarter reported on 11/9/2026. New results are added as companies report their earnings.
From Our Partners